BSE filing, NSE: BI. Summary written from the filing by ALFA Finder's alert engine.
Bilcare Ltd: key numbers
- Share price
- ₹81.12
- Market cap
- ₹191.0 Cr
- Revenue (annual)
- ₹733.5 Cr
- Net profit (annual)
- ₹1.73 Cr
- P/E (TTM)
- 24.6×Sector 52.0×
- Promoter holding
- 30.01%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bilcare Ltd
All →Bilcare Board Meeting Date
Bilcare Limited scheduled a board meeting for 3 November 2026 to consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The results have not yet been approved, so this is only a notice.
Bilcare Other Announcement
Bilcare Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing details shareholding distribution among promoters and the public.
Bilcare Annual General Meeting
Bilcare Limited issued a corrigendum for its 39th Annual General Meeting, correcting a clerical error where a director's appointment resolution was mislabeled as a special resolution.
Bilcare Capital Structure Change
Non-promoter Guttikonda Anuradha, Vara Lakshmi and Rajasekhar bought 4,73,264 Bilcare shares in the open market, lifting PAC holdings to 16.47%. No transaction price was disclosed.
Bilcare Management Change
Bilcare Limited has appointed Mr. Mohan Bhandari and re-appointed Ms. Kavita Bhansali as Executive Directors for a three-year term, effective August 2026.
Bilcare Annual General Meeting
Bilcare Limited issued the Notice for its 39th Annual General Meeting scheduled for September 26, 2026, to transact six agenda items, including related party transaction approvals.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr